#antivirals — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #antivirals, aggregated by home.social.
-
Occurrence of #influenza #antivirals and #resistance development in #influenza A viruses in aquatic #environments: A risk assessment, https://etidiohnew.blogspot.com/2026/09/occurrence-of-influenza-antivirals-and.html
-
Occurrence of #influenza #antivirals and #resistance development in #influenza A viruses in aquatic #environments: A risk assessment, https://etidiohnew.blogspot.com/2026/09/occurrence-of-influenza-antivirals-and.html
-
Occurrence of #influenza #antivirals and #resistance development in #influenza A viruses in aquatic #environments: A risk assessment, https://etidiohnew.blogspot.com/2026/09/occurrence-of-influenza-antivirals-and.html
-
Occurrence of #influenza #antivirals and #resistance development in #influenza A viruses in aquatic #environments: A risk assessment, https://etidiohnew.blogspot.com/2026/09/occurrence-of-influenza-antivirals-and.html
-
#Mutations in severe #human #H5N1 cases facilitate #evasion from human mucus and #antivirals, https://etidiohnew.blogspot.com/2026/07/mutations-in-severe-human-h5n1-cases.html
-
#Mutations in severe #human #H5N1 cases facilitate #evasion from human mucus and #antivirals, https://etidiohnew.blogspot.com/2026/07/mutations-in-severe-human-h5n1-cases.html
-
#Mutations in severe #human #H5N1 cases facilitate #evasion from human mucus and #antivirals, https://etidiohnew.blogspot.com/2026/07/mutations-in-severe-human-h5n1-cases.html
-
#Mutations in severe #human #H5N1 cases facilitate #evasion from human mucus and #antivirals, https://etidiohnew.blogspot.com/2026/07/mutations-in-severe-human-h5n1-cases.html
-
Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the… #science #multiplesclerosis #antivirals
Posted into FLIPBOARD EXCHANGE FEED 🗞️ @flipboard-exchange-feed-Econopass
-
Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the… #science #multiplesclerosis #antivirals
Posted into FLIPBOARD EXCHANGE FEED 🗞️ @flipboard-exchange-feed-Econopass
-
Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the… #science #multiplesclerosis #antivirals
Posted into FLIPBOARD EXCHANGE FEED 🗞️ @flipboard-exchange-feed-Econopass
-
A Sea Anemone Uses CARDIB to Fight Viruses—and It’s Even More Bizarre Than It Sounds
Floating outside the salt marsh silt it usually nestles in, the starlet sea anemone (Nematostella vectensis) looks a…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Science #antivirals #marineanimals #MARINECONSERVATION #medicaldiscoveries
https://www.newsbeep.com/us/739902/ -
https://www.europesays.com/ch/87091/ Roche signs generic Xofluza licensing deal with MPP #AntiviralDrug #antivirals #FiercePharmaHomepage #influenza #Manufacturing #MedicinesPatentPool #PandemicPreparedness #Pharma #Roche #SeasonalFlu #Xofluza
-
Okogen acquires ranpirnase IP portfolio from Orgenesis, strengthening its antiviral pipeline for eye infections, respiratory viruses, and emerging infectious diseases. Lead candidate OKG-0303 targets unmet needs in conjunctivitis treatment. #Biotech #Antivirals
-
Okogen acquires ranpirnase IP portfolio from Orgenesis, strengthening its antiviral pipeline for eye infections, respiratory viruses, and emerging infectious diseases. Lead candidate OKG-0303 targets unmet needs in conjunctivitis treatment. #Biotech #Antivirals
-
Okogen acquires ranpirnase IP portfolio from Orgenesis, strengthening its antiviral pipeline for eye infections, respiratory viruses, and emerging infectious diseases. Lead candidate OKG-0303 targets unmet needs in conjunctivitis treatment. #Biotech #Antivirals
-
Okogen acquires ranpirnase IP portfolio from Orgenesis, strengthening its antiviral pipeline for eye infections, respiratory viruses, and emerging infectious diseases. Lead candidate OKG-0303 targets unmet needs in conjunctivitis treatment. #Biotech #Antivirals
-
NanoViricides' NV-387 receives FDA Orphan Drug Designation for measles treatment, unlocking tax credits and market exclusivity. The broad-spectrum antiviral advances toward Phase II trials. #Biotech #Antivirals
-
NanoViricides' NV-387 receives FDA Orphan Drug Designation for measles treatment, unlocking tax credits and market exclusivity. The broad-spectrum antiviral advances toward Phase II trials. #Biotech #Antivirals
-
NanoViricides' NV-387 receives FDA Orphan Drug Designation for measles treatment, unlocking tax credits and market exclusivity. The broad-spectrum antiviral advances toward Phase II trials. #Biotech #Antivirals
-
NanoViricides' NV-387 receives FDA Orphan Drug Designation for measles treatment, unlocking tax credits and market exclusivity. The broad-spectrum antiviral advances toward Phase II trials. #Biotech #Antivirals
-
NanoViricides to present broad-spectrum antiviral pipeline at D. Boral Capital Global Conference in NYC on May 7. Lead candidate NV-387 completed Phase I trials with zero adverse events. #Biotech #Antivirals
-
NanoViricides to present broad-spectrum antiviral pipeline at D. Boral Capital Global Conference in NYC on May 7. Lead candidate NV-387 completed Phase I trials with zero adverse events. #Biotech #Antivirals
-
NanoViricides to present broad-spectrum antiviral pipeline at D. Boral Capital Global Conference in NYC on May 7. Lead candidate NV-387 completed Phase I trials with zero adverse events. #Biotech #Antivirals
-
NanoViricides to present broad-spectrum antiviral pipeline at D. Boral Capital Global Conference in NYC on May 7. Lead candidate NV-387 completed Phase I trials with zero adverse events. #Biotech #Antivirals
-
NanoViricides advances broad-spectrum antiviral NV-387 following Andes hantavirus incident. Phase I trial completed successfully; animal models show efficacy against COVID, RSV, influenza, and monkeypox. #Biotech #Antivirals
-
NanoViricides advances broad-spectrum antiviral NV-387 following Andes hantavirus incident. Phase I trial completed successfully; animal models show efficacy against COVID, RSV, influenza, and monkeypox. #Biotech #Antivirals
-
NanoViricides advances broad-spectrum antiviral NV-387 following Andes hantavirus incident. Phase I trial completed successfully; animal models show efficacy against COVID, RSV, influenza, and monkeypox. #Biotech #Antivirals
-
NanoViricides advances broad-spectrum antiviral NV-387 following Andes hantavirus incident. Phase I trial completed successfully; animal models show efficacy against COVID, RSV, influenza, and monkeypox. #Biotech #Antivirals
-
Antiviral activities of multiple #antivirals against highly pathogenic avian #influenza A #H5N1 in vitro and in mice, https://etidiohnew.blogspot.com/2026/03/antiviral-activities-of-multiple.html
-
Antiviral activities of multiple #antivirals against highly pathogenic avian #influenza A #H5N1 in vitro and in mice, https://etidiohnew.blogspot.com/2026/03/antiviral-activities-of-multiple.html
-
Antiviral activities of multiple #antivirals against highly pathogenic avian #influenza A #H5N1 in vitro and in mice, https://etidiohnew.blogspot.com/2026/03/antiviral-activities-of-multiple.html
-
Antiviral activities of multiple #antivirals against highly pathogenic avian #influenza A #H5N1 in vitro and in mice, https://etidiohnew.blogspot.com/2026/03/antiviral-activities-of-multiple.html
-
Excited to share our paper in Journal of Medicinal #Chemistry exploring carbobicyclic nucleoside analogues as potential #antivirals!
We swapped the ribose oxygen for a carbon in nucleoside analogues and explored this novel scaffold.
From our library, several compounds showed activity against #HCV, #HSV, #influenza, and #RSV. One uracil-based analogue stood out by inhibiting multiple viruses like #flu and HCV. Modeling suggests it “locks” the viral active site instead of being incorporated into RNA.
What really surprised us: nucleobases with known antiviral effects (like NHC from molnupiravir) didn’t work in our scaffold—but unmodified uracil did. The scaffold itself changes how these molecules behave.
Encouragingly, these compounds phosphorylate efficiently in cells without needing prodrugs, don't inhibit human polymerases, and our #synthesis is efficient: 28 pyrimidine and 35 purine analogues from just two intermediates in under 10 steps.
Huge thanks to all collaborators and colleagues who made this work possible!
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02584
J. Med. Chem. 2026, 69, 5, 5501–5539.
-
Excited to share our paper in Journal of Medicinal #Chemistry exploring carbobicyclic nucleoside analogues as potential #antivirals!
We swapped the ribose oxygen for a carbon in nucleoside analogues and explored this novel scaffold.
From our library, several compounds showed activity against #HCV, #HSV, #influenza, and #RSV. One uracil-based analogue stood out by inhibiting multiple viruses like #flu and HCV. Modeling suggests it “locks” the viral active site instead of being incorporated into RNA.
What really surprised us: nucleobases with known antiviral effects (like NHC from molnupiravir) didn’t work in our scaffold—but unmodified uracil did. The scaffold itself changes how these molecules behave.
Encouragingly, these compounds phosphorylate efficiently in cells without needing prodrugs, don't inhibit human polymerases, and our #synthesis is efficient: 28 pyrimidine and 35 purine analogues from just two intermediates in under 10 steps.
Huge thanks to all collaborators and colleagues who made this work possible!
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02584
J. Med. Chem. 2026, 69, 5, 5501–5539.
-
Excited to share our paper in Journal of Medicinal #Chemistry exploring carbobicyclic nucleoside analogues as potential #antivirals!
We swapped the ribose oxygen for a carbon in nucleoside analogues and explored this novel scaffold.
From our library, several compounds showed activity against #HCV, #HSV, #influenza, and #RSV. One uracil-based analogue stood out by inhibiting multiple viruses like #flu and HCV. Modeling suggests it “locks” the viral active site instead of being incorporated into RNA.
What really surprised us: nucleobases with known antiviral effects (like NHC from molnupiravir) didn’t work in our scaffold—but unmodified uracil did. The scaffold itself changes how these molecules behave.
Encouragingly, these compounds phosphorylate efficiently in cells without needing prodrugs, don't inhibit human polymerases, and our #synthesis is efficient: 28 pyrimidine and 35 purine analogues from just two intermediates in under 10 steps.
Huge thanks to all collaborators and colleagues who made this work possible!
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02584
J. Med. Chem. 2026, 69, 5, 5501–5539.
-
Excited to share our paper in Journal of Medicinal #Chemistry exploring carbobicyclic nucleoside analogues as potential #antivirals!
We swapped the ribose oxygen for a carbon in nucleoside analogues and explored this novel scaffold.
From our library, several compounds showed activity against #HCV, #HSV, #influenza, and #RSV. One uracil-based analogue stood out by inhibiting multiple viruses like #flu and HCV. Modeling suggests it “locks” the viral active site instead of being incorporated into RNA.
What really surprised us: nucleobases with known antiviral effects (like NHC from molnupiravir) didn’t work in our scaffold—but unmodified uracil did. The scaffold itself changes how these molecules behave.
Encouragingly, these compounds phosphorylate efficiently in cells without needing prodrugs, don't inhibit human polymerases, and our #synthesis is efficient: 28 pyrimidine and 35 purine analogues from just two intermediates in under 10 steps.
Huge thanks to all collaborators and colleagues who made this work possible!
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02584
J. Med. Chem. 2026, 69, 5, 5501–5539.
-
Insightful talk by Clemens Richert at #Biochemistry2026. He talked about his group’s work on optimized #antivirals. He gave exciting insights into the optimization of prodrugs of nucleotides #ProTides.
#Biochemistry #Chemistry #ChemBio #Virus #DrugDiscovery
CC: @gdch, @GDCh_BioChem -
Insightful talk by Clemens Richert at #Biochemistry2026. He talked about his group’s work on optimized #antivirals. He gave exciting insights into the optimization of prodrugs of nucleotides #ProTides.
#Biochemistry #Chemistry #ChemBio #Virus #DrugDiscovery
CC: @gdch, @GDCh_BioChem -
Insightful talk by Clemens Richert at #Biochemistry2026. He talked about his group’s work on optimized #antivirals. He gave exciting insights into the optimization of prodrugs of nucleotides #ProTides.
#Biochemistry #Chemistry #ChemBio #Virus #DrugDiscovery
CC: @gdch, @GDCh_BioChem -
Insightful talk by Clemens Richert at #Biochemistry2026. He talked about his group’s work on optimized #antivirals. He gave exciting insights into the optimization of prodrugs of nucleotides #ProTides.
#Biochemistry #Chemistry #ChemBio #Virus #DrugDiscovery
CC: @gdch, @GDCh_BioChem -
Interesting talk by Foteini Skoulikopoulou of the group of Zach Armstrong of the @LED3hub at #NWOCHAINS. She talked about her research into the synthesis of stable 9-O-acetylated sialic acid mimics with potential applications as #antivirals.
-
Interesting talk by Foteini Skoulikopoulou of the group of Zach Armstrong of the @LED3hub at #NWOCHAINS. She talked about her research into the synthesis of stable 9-O-acetylated sialic acid mimics with potential applications as #antivirals.
-
Interesting talk by Foteini Skoulikopoulou of the group of Zach Armstrong of the @LED3hub at #NWOCHAINS. She talked about her research into the synthesis of stable 9-O-acetylated sialic acid mimics with potential applications as #antivirals.
-
The poster pitches at #NWOCHAINS were an absolute firework of great science. We learned about #antivirals, #organocatalysis, #MolecularMotors, #EnzymeEngineering, #photocontrol, #odor detection, sensing of #bacteria, #recycling, #batteries, #QuantumDots, #vitrimers, #BoneRegeneration, native #MassSpectrometry and #biomaterials. Always one of my highlights of the conference.
-
The poster pitches at #NWOCHAINS were an absolute firework of great science. We learned about #antivirals, #organocatalysis, #MolecularMotors, #EnzymeEngineering, #photocontrol, #odor detection, sensing of #bacteria, #recycling, #batteries, #QuantumDots, #vitrimers, #BoneRegeneration, native #MassSpectrometry and #biomaterials. Always one of my highlights of the conference.
-
The poster pitches at #NWOCHAINS were an absolute firework of great science. We learned about #antivirals, #organocatalysis, #MolecularMotors, #EnzymeEngineering, #photocontrol, #odor detection, sensing of #bacteria, #recycling, #batteries, #QuantumDots, #vitrimers, #BoneRegeneration, native #MassSpectrometry and #biomaterials. Always one of my highlights of the conference.
-
Journal Article
🌱 #Cannabis as #antivirals Open Access
Yi Lin Sea, Yee Jing Gee, Sunil Kumar Lal, Wee Sim Choo
Journal of Applied Microbiology, Volume 134, Issue 1, January 2023,https://academic.oup.com/jambio/article/134/1/lxac036/6902073
#science #Studie #Demokratie #Medizin #Politik #Merz #Söder #Bas #Schwerdtner #Klingbeil #ThorstenFrei #Reiche #Klimaschutz #Cannabisgeschichten #hanf #Gesundheit #CanG #Menschenrechte #SPD #CSU #CDU #DIELINKE #FDP #GRÜNE #DHV #Cannabis #CaNoKo25 #medizin #viren #antiviral #Forschung
-
Journal Article
🌱 #Cannabis as #antivirals Open Access
Yi Lin Sea, Yee Jing Gee, Sunil Kumar Lal, Wee Sim Choo
Journal of Applied Microbiology, Volume 134, Issue 1, January 2023,https://academic.oup.com/jambio/article/134/1/lxac036/6902073
#science #Studie #Demokratie #Medizin #Politik #Merz #Söder #Bas #Schwerdtner #Klingbeil #ThorstenFrei #Reiche #Klimaschutz #Cannabisgeschichten #hanf #Gesundheit #CanG #Menschenrechte #SPD #CSU #CDU #DIELINKE #FDP #GRÜNE #DHV #Cannabis #CaNoKo25 #medizin #viren #antiviral #Forschung
-
Journal Article
🌱 #Cannabis as #antivirals Open Access
Yi Lin Sea, Yee Jing Gee, Sunil Kumar Lal, Wee Sim Choo
Journal of Applied Microbiology, Volume 134, Issue 1, January 2023,https://academic.oup.com/jambio/article/134/1/lxac036/6902073
#science #Studie #Demokratie #Medizin #Politik #Merz #Söder #Bas #Schwerdtner #Klingbeil #ThorstenFrei #Reiche #Kulturkampf #Klimaschutz #Hanfgeschichten #hanf #Gesundheit #CanG #Menschenrechte #SPD #CSU #CDU #DIELINKE #FDP #GRÜNE #DHV #Cannabis #CaNoKo25 #medizin #viren #antiviral #Forschung
-
Journal Article
🌱 #Cannabis as #antivirals Open Access
Yi Lin Sea, Yee Jing Gee, Sunil Kumar Lal, Wee Sim Choo
Journal of Applied Microbiology, Volume 134, Issue 1, January 2023,https://academic.oup.com/jambio/article/134/1/lxac036/6902073
#science #Studie #Demokratie #Medizin #Politik #Merz #Söder #Bas #Schwerdtner #Klingbeil #ThorstenFrei #Reiche #Kulturkampf #Klimaschutz #Hanfgeschichten #hanf #Gesundheit #CanG #Menschenrechte #SPD #CSU #CDU #DIELINKE #FDP #GRÜNE #DHV #Cannabis #CaNoKo25 #medizin #viren #antiviral #Forschung
-
Thanks for being the #Covid guy and doing all the hard background #research for your posts. To add my lazy two-cents worth I recently got a real bad dose of Covid and it was the worst “dose of flu” that I have suffered.
It was about four days before I even thought to test myself feeling bad enough for Hospital. Stupid, because I am elderly and have heart problems.
#Antivirals made me feel a lot better.
I’m fully #vaccinated but the latest strain finally got through! Picked up at a local shopping centre.
I plan to start wearing an #N95 each time I visit a large shopping centre now, just like the old days. 👍🧐🧐🧐
-
Thanks for being the #Covid guy and doing all the hard background #research for your posts. To add my lazy two-cents worth I recently got a real bad dose of Covid and it was the worst “dose of flu” that I have suffered.
It was about four days before I even thought to test myself feeling bad enough for Hospital. Stupid, because I am elderly and have heart problems.
#Antivirals made me feel a lot better.
I’m fully #vaccinated but the latest strain finally got through! Picked up at a local shopping centre.
I plan to start wearing an #N95 each time I visit a large shopping centre now, just like the old days. 👍🧐🧐🧐
-
Thanks for being the #Covid guy and doing all the hard background #research for your posts. To add my lazy two-cents worth I recently got a real bad dose of Covid and it was the worst “dose of flu” that I have suffered.
It was about four days before I even thought to test myself feeling bad enough for Hospital. Stupid, because I am elderly and have heart problems.
#Antivirals made me feel a lot better.
I’m fully #vaccinated but the latest strain finally got through! Picked up at a local shopping centre.
I plan to start wearing an #N95 each time I visit a large shopping centre now, just like the old days. 👍🧐🧐🧐
-
🔁📄 'Repositioning antivirals against COVID-19: Synthetic pathways, mechanisms, and therapeutic insights.' - a #DrugRepurposing Research article on #ScienceOpen:
➡️ https://www.scienceopen.com/document?vid=86a9a26d-fa33-4c20-8ef2-41c90ddc56fa
#REPO4EU #COVID19Research #Antivirals #MedicinalChemistry #SyntheticChemistry
-
🔁📄 'Repositioning antivirals against COVID-19: Synthetic pathways, mechanisms, and therapeutic insights.' - a #DrugRepurposing Research article on #ScienceOpen:
➡️ https://www.scienceopen.com/document?vid=86a9a26d-fa33-4c20-8ef2-41c90ddc56fa
#REPO4EU #COVID19Research #Antivirals #MedicinalChemistry #SyntheticChemistry